Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Gastroenterol Hepatol ; 32(11): 1832-1838, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28387430

RESUMO

BACKGROUND AND AIM: Although the esophagus is a common site of opportunistic infection in AIDS patients, little is known about the impact of HIV as well as opportunistic infection in the esophageal mucosa. Our aim is to analyze the esophageal immune profile in HIV+ patients with different immunological status with and without the opportunistic Candida infection. METHODS: Immunohistochemistry to CD4+ and CD8+ T-cells, γ-interferon, transforming growth factor-ß, interleukin (IL)-4, IL-6, IL-13, and IL-17 was performed in esophageal samples of 40 chronically HIV+ patients under highly active antiretroviral therapy (16 with Candida esophagitis, 12 virologically non-supressed with blood CD4 count < 500, and 12 virologically suppressed with blood CD4 count > 500; the latter two groups without esophageal candidiasis). The controls were 12 HIV-negative healthy individuals. RESULTS: Esophageal CD4+ T-cell expression in HIV+ patients did not differ from the control group (P = 0.50). Mucosal CD8+ T-cell expression was significantly increased in HIV+ patients (P = 0.0018). Candida esophagitis and virologically non-supressed HIV+ patients with CD4 < 500 showed an increased expression of IL-17 and IL-6 with fewer expressions of γ-interferon, more attenuated in the latter group. Transforming growth factor-ß was increased only in virologically suppressed HIV+ patients with CD4 > 500. IL-4 and IL-13 were similar to the control group. CONCLUSION: In contrast to CD8+ T-cell expression, esophageal CD4+ T-cell expression does not reflect the HIV+ patient's immunological status. T-helper 17 (Th17) response seems to play a role in the esophageal mucosa of virologically non-supressed HIV+ patients with blood CD4 < 500. Candida esophagitis showed a Th1/Th17 response but seems to be dominantly regulated by the Th17 pathway.


Assuntos
Candidíase/complicações , Mucosa Esofágica/imunologia , Esofagite/microbiologia , Infecções por HIV/complicações , Infecções Oportunistas/complicações , Adulto , Linfócitos T CD4-Positivos , Linfócitos T CD8-Positivos , Candidíase/imunologia , Esofagite/imunologia , Feminino , Infecções por HIV/imunologia , Humanos , Interleucina-17 , Interleucina-6 , Masculino , Pessoa de Meia-Idade , Infecções Oportunistas/imunologia , Fator de Crescimento Transformador beta
2.
JOP ; 15(3): 237-42, 2014 May 27.
Artigo em Inglês | MEDLINE | ID: mdl-24865534

RESUMO

CONTEXT: Several mechanisms are involved in the development of the local and systemic response in acute pancreatitis. Cardiovascular system may be affected throughout the clinical course of acute pancreatitis. The aim was to evaluate local myocardial cytokine production, as well as, functional and histological myocardial alterations in severe acute pancreatitis. METHODS: The animals were divided into three groups: Group 1: control; Group 2: sham; Group 3: severe acute pancreatitis. Echocardiographic assessment of cardiac function, serum levels of amylase and cytokines (TNF-α, IL-6 and IL-10), and mRNA expression of TNF-α, IL-6 and TGF-ß were measured. Myocardial tissue alterations were analysed by histological examination. RESULTS: The serum TNF-α and IL-10 levels were significant higher in AP 2h group. The mRNA IL-6 levels from group AP 2h were statistically higher. The mRNA TNF-α level from sham group and AP 2h were statistically lower. Significant changes in the left ventricular diameter were found in AP 2h and AP 12h groups. There were statistical changes for vacuolar degeneration, picnosis and loss of nucleus, and lymphocytes. CONCLUSION: We found cardiac and histological changes compatible with the inflammatory process triggered by SAP with the promotion of local myocardial cytokine production.


Assuntos
Citocinas/imunologia , Cardiopatias/imunologia , Miocárdio/imunologia , Pancreatite/imunologia , Doença Aguda , Amilases/sangue , Animais , Biópsia , Citocinas/genética , Citocinas/metabolismo , Ecocardiografia , Cardiopatias/metabolismo , Cardiopatias/patologia , Testes de Função Cardíaca , Mediadores da Inflamação/sangue , Interleucina-10/genética , Interleucina-10/imunologia , Interleucina-10/metabolismo , Interleucina-6/genética , Interleucina-6/imunologia , Interleucina-6/metabolismo , Masculino , Miocárdio/metabolismo , Pancreatite/metabolismo , Pancreatite/patologia , RNA Mensageiro/metabolismo , Ratos Wistar , Índice de Gravidade de Doença , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/imunologia , Fator de Necrose Tumoral alfa/metabolismo
3.
J Heart Lung Transplant ; 26(11): 1091-6, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18022073

RESUMO

BACKGROUND: Chagas' disease is endemic in many Latin American countries. In the last decades, millions of people from these countries have migrated to the United States, changing the scenario of acute Chagas' disease associated with blood transfusion in North America. METHODS AND RESULTS: We report the case of a chagasic patient who developed intracranial hypertension and focal neurologic signs 7 months after heart transplantation. Immunosuppression after transplantation was achieved with prednisone, cyclosporine A, and mycophenolate mofetil. Cranial magnetic resonance imaging revealed a right temporoparietal mass lesion with surrounding edema. Trypanosoma cruzi was observed in the cerebrospinal fluid by Giemsa method, and autopsy disclosed a cerebral chagoma with amastigote forms of T cruzi, with neither associated myocarditis nor systemic infection. CONCLUSION: In chagasic patients who undergo heart transplantation and immunosuppression, the risk of late reactivation of Chagas' disease by means of an isolated cerebral mass lesion must be considered.


Assuntos
Cardiomiopatia Chagásica/cirurgia , Doença de Chagas/complicações , Doença de Chagas/diagnóstico , Encefalite/diagnóstico , Encefalite/etiologia , Transplante de Coração/efeitos adversos , Animais , Encéfalo/parasitologia , Encéfalo/patologia , Humanos , Terapia de Imunossupressão/métodos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Recidiva , Trypanosoma cruzi/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA